Durect Corp
About
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Growth
DURECT Corporation is a late-stage biopharmaceutical company that is focused on utilizing epigenetic modulation to potentially treat serious and life-threatening conditions, such as acute organ injury and cancer. The company is at an advanced growth stage, with a strong emphasis on developing novel epigenetic therapies to improve patient outcomes and revolutionize medicine. DURECT is actively engaged in clinical trials and partnerships to further advance its technology and therapeutic options.
Achievements
DURECT Corporation has achieved significant milestones in its history, including the completion of a Phase 2b study (AHFIRM) in subjects with severe alcohol-associated hepatitis (AH). The company's first epigenetic modulator, larsucosterol, shows promising potential to save lives of patients with AH, as indicated by the clinical trial results. Moreover, DURECT has announced the design of a Phase 3 registrational trial for larsucosterol in alcohol-associated hepatitis, marking a crucial step towards seeking regulatory approval for this innovative therapy.
Case Studies
One of the notable case studies involving DURECT Corporation is the AHFIRM trial, which evaluated the efficacy of larsucosterol in patients with severe alcohol-associated hepatitis. The results of this trial demonstrated promising effects on mortality rates, indicating the potential of this epigenetic modulator to improve patient outcomes in a critical medical condition. This case study underscores the importance of epigenetic modulation in addressing complex diseases such as AH.
Socials
Website
Founded
-
Operating Status
Active
Industry
Health Care/Life Sciences
headquarters
Address
10240 Bubb Road Cupertino California 95014 United States...
Country
United States
Employees
79
Key People
Mohammad Magdy Mohamed Azab (Independent Director)
Gail M. Farfel (Director)
Judy R. Joice (Senior VP-Operations & Corporate Quality Assurance)
Timothy M. Papp (Chief Financial Officer & Secretary)
Revenue
19.28 M
Operating Income
Stock Price
$1.43
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
Similar Companies
Welcome to AiDOOS Wiki
AiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
Durect Corp
-
Website
-
Founded
-
-
Industry
Health Care/Life Sciences
-
Address
10240 Bubb Road Cupertino California 95014 United States...
-
Country
United States
-
Number of employees
79+
-
Revenue
19.28 M
About Durect Corp
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
